Additionally, AUC of PD-L1+CD20+ % was 1.0 for predicting patients with DLBCL from healthy controls [p < 0.001], however, PD-1+CD20+ % AUC was 0.767 for identifying patients with DLBCL from healthy volunteers (p < 0.001) (Figure 5C,E). This evidence concerns the gene CD274 and diffuse large B-cell lymphoma.